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ABSTRACT
A computer-aided diagnostic (CAD) system that uses a unique shape-based
classification scheme, the Ellipse-Closed Curve Fitting (ECCF) algorithm, is developed
for digital mammogram image analysis. The system is developed to work as a postprocessing extension to a previously developed CAD system that locates and segments
mass lesions, or tumors, found in digital mammograms into separate images. The ECCF
system is implemented in the MATLAB mathematical scripting language and is thus
capable of running on multiple platforms.
The ECCF algorithm detects edges in tumor images and casts them into closed
curve functions. Parameters for an ellipse of best fit for a closed curve function are
computed in a way analogous to that in linear regression, where a line of best fit is
determined to fit a set of data points.
In addition to the shape-fitting algorithm, the ECCF system comprises several
other independently functioning components, including auxiliary algorithms and
techniques that perform image cropping and edge detection, employed initially to prepare
the images for efficient processing, and self-test tools that calculate R2, area matching
ratios, and a "shape conformity value" to determine the "goodness of fit". Output
generated by the ECCF system for sufficiently large image sets may contain correlations
between malignant tumors and their shape that may be captured with data mining
techniques, the implementation of which may result in an improved integrated CAD
system.
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CHAPTER 1 - INTRODUCTION
Breast Cancer
Breast cancer is the uncontrolled growth of abnormal cells in the breast. As with
other forms of cancer, breast cancer is considered to be a result of malfunctioning DNA
due to damage or inherited mutation. Breast cancer is a disease that typically develops in
women; however, it is also possible, although rare, for breast cancer to develop in men.
According to the World Health Organization, more than 1.2 million people worldwide
will learn they have breast cancer this year. The American Cancer Society estimates
women in the United States will account for approximately 213,000 of these cases. The
National Cancer Institute (NCI) reports breast cancer as the most common type of cancer
among women in the US, second only to skin cancer [1].
Breast Cancer Statistics
Breast cancer ranks second to lung cancer as the leading cause of death in women
diagnosed with cancer in the US. About 41,000 women in the US are expected to die
from the disease in 2006.[2] The number of cases of women with breast cancer has been
increasing. In 2005, 211,240 women in the US were diagnosed with breast cancer,
compared to ~7,522 women in 1975, which comes out to an average increase of about
0.4% per year. However, over the last decade, due to increased awareness, screening, and
improved treatments, the number of deaths due to breast cancer has been decreasing
overall.[3] Figure 1.1 shows death rates due to breast cancer in comparison to other types
of cancer over the last seven decades.
Currently there is no cure for breast cancer, and it is also not possible to predict
when or if a person will develop the disease. Early detection and treatment are currently
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the only means proven to reduce breast cancer related mortality rates. It is therefore
important for women especially to avoid the risk factors for breast cancer, monitor
themselves for its symptoms, and get screened periodically for the disease.

Figure 1.1: Age-adjusted cancer death rates of women in the US between 1930-2002.
Overall, deaths due to breast cancer have been declining since 1990 yet it remains the
second leading killer of women diagnosed with cancer in the US.

Mammography and Breast Cancer Screening
Mammography is the study that involves identifying structures within the breast
to classify them as benign or malignant. A mammogram is an image obtained by using Xrays to probe the breast. During a screening for breast cancer radiologists, or readers,
inspect mammogram for areas that may indicate further investigation through biopsy, a
surgical procedure from which the diagnosis and subsequent prognosis is obtained.
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Routine mammography reduces the breast cancer mortality rate by 25% to 35% in
asymptomatic middle-aged women. The National Cancer Institute recommends annual
mammograms for women above 50 years of age. However, medical science is not exact.
Readings are subject to error, thus diagnostics are not 100% accurate. Nevertheless, the
field of mammography has benefited from continuous advances in technology over time.
Today, two kinds of mammography are in clinical use, conventional film
mammography and digital mammography. Each has comparative advantages and
disadvantages with respect to the other. Despite its drawbacks, digital mammography is
however potentially superior to film mammography particularly as it can be used along
with CAD (computer-aided detection or computer-aided diagnostic) systems. CAD
systems have been demonstrated as effective tools for helping radiologist identify
malignancies in mammograms. Research activity in digital mammography and CAD
systems is relatively new, beginning in the late 1980's. The area is now nevertheless
recognized as an important area of research in and across a number of industrial and
academic sites around the world.
Basically, the goal of development in these areas is to improve the precision of
the CAD process. In this thesis we present a CAD and an attempt to improve the
performance of this CAD system using a tumor shape analysis algorithm.
Chapter Outline
The outline of the remaining portion of this thesis is as follows: Chapter 2 will
cover aspects of breast cancer treatment. Conventional film mammography, digital
mammography, and computer-aided diagnostic systems will be covered in Chapter 3.
Descriptions of the CAD system developed by Sample and Tyler and the post-screening
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shape analysis (PSA) system will be described in Chapter 4. Results and conclusions are
presented in Chapter 5.
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CHAPTER 2 – BREAST CANCER TREATMENT
Risk Factors and Prevention
As previously stated, gender is the most significant factor affecting the likelihood
of one developing breast cancer. High blood levels of estrogen have been associated with
breast cancer. Women are about 90 times more likely to develop breast cancer than men.
Besides gender, age is the next most strongly correlated risk factor of breast cancer. The
odds of a female developing breast cancer before age 39 is 1 in 209. By the time she
becomes 40 those odds increase by almost 9-fold to 1 in 24, as can be seen in Figure 2.1.
The US National Cancer Institute suggests that women have their first mammogram at
age 35, every two years after age 40, and then annually after 50.
Genetics also plays a role. Women with a personal or family history of breast
cancer are being advised to have more frequent and even extensive examinations. It is
usually suggested to start screening when a women reaches 10 years less than the age at
which the relative was diagnosed with breast cancer. Exposure to radiation or various
carcinogenic chemicals can increase the likelihood of developing breast cancer.
Reproductive factors also play a role in the chances of developing breast cancer. Women
that start menstruating or enter menopause later than average are more likely to get breast
cancer. Women who have children later in life or who do not breast-feed are more likely
to get breast cancer. Women have control over some significant risk factors of breast
cancer in their modifiable habits. It is suggested that woman quit, or never start, smoking
and reduce their exposure to 2nd and 3rd hand smoke as much as possible. Excessive
alcohol consumption, more than one alcoholic beverage per day, has also been shown to
have a positive correlation with the occurrence of breast cancer. Also women who are
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obese are more likely to develop breast cancer. Thus a healthy diet and regular exercise
may also decrease the risk of developing cancer.
In some cases, knowing the risk factors can help women reduce their likelihood of
developing breast cancer by making lifestyle choices. In cases where genetics or the
environment creates a predisposition to the disease, women should have earlier and more
frequent exams as well as closer monitoring for symptoms.

Figure 2.1: Probability of developing invasive cancers over selected age intervals and by
gender US populations based on cases diagnosed during 2000 to 2002. Subjects are
cancer free at the beginning of an age interval. 1 in 24 women between the ages of 40 and
59 are likely to develop breast cancer. The chance of developing breast cancer increases
with age. 1 out of 8 women will develop breast cancer at some point over their life time.

Symptoms
Breast cancer may be accompanied by any of a number of symptoms. Abnormal
lumps persisting in the breast are perhaps one of the most commonly associated
symptoms. Skin dimpling, unusual changes in texture or skin color on the breast, change
in the shape of the nipple, and discharge of blood through the nipple may also be
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symptoms of breast cancer as shown in Figure 2.2. In some cases of breast cancer,
however, there are no noticeable symptoms. In fact, half of women who get breast cancer
experience no obvious symptoms and discover their breast cancer only after undergoing a
medical examination.[4] Therefore, it is important for women to have periodic screenings
for breast cancer.

Figure 2.2: Illustrations of early signs of breast cancer. (Image originally from the
National Institutes for Health.)
Breast Cancer Screening
Self-examinations for breast cancer are a very important part of health
maintenance. They should be performed regularly and frequently as a first line of defense
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against breast cancer. However, since about 50% of breast cancers go undetected by selfexamination, professional medical screenings should also be used in conjunction with
self-examination for precaution. Breast cancer screening is a professional medical
examination performed to check women's breasts for abnormalities such as tumors and
cysts and identify malignancies where they exist. It is widely available in the U.S. and is
highly recommended as it has been proven to significantly reduce fatalities due to breast
cancer.
Several techniques can be used to examine the breast including ultrasound, which
uses a band of high frequency sound waves to probe the breast; magnetic resonance
imaging, which probes the breast using powerful magnetic fields; and mammography,
which is essentially producing X-ray photographs of the breast. Mammography will be
discussed in more detail in Chapter 3. A screening will basically involve mammography
or getting a mammogram, but some cases may involve all three examination methods for
thorough investigations. In any case, the screening process is simply used to find
abnormalities in the breast, not to obtain a diagnosis.
Diagnosis
A diagnosis is the process of identifying a disease by its signs, symptoms and
results of various diagnostic procedures. The conclusion reached through that process as
to whether a tumor is malignant (cancerous) or benign (non-cancerous) is also called a
diagnosis. Diagnoses can only be obtained through biopsy with present technologies and
procedures. The term biopsy refers in general to a procedure where tissue is removed for
examination from areas in the body where cancer is suspected. There are specific biopsies
for different sites in the body: liver, skin, bone marrow, prostate and various others. For
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the breast alone there are several kinds of biopsies including fine-needle aspiration,
nipple aspirates, ductal lavage, core needle biopsy, and local surgical biopsy. Each has
comparative advantages and limitations. No method of biopsy is perfect. Sometimes
cancers can still be missed if an ample amount of tissue is not sampled or if the tissue is
sampled from the wrong place altogether.
Particular questions a biopsy is intended to resolve are: What's the size of the
tumor? Is the tumor cancerous? Are lymph nodes involved? Once cancer has been found
at a site, there is the question of metastasis, or in other words, has the cancer spread to
other places in the body from that site and how aggressively is it spreading. The
spreading of cancer is called metastasis. Methods used to check for metastasis are chest
x-ray, bone scan, computed tomography (CT), magnetic resonance imaging (MRI), and
positron emission tomography. Tumor markers are also used to trace where cancer has
spread in the body. Data collected from biopsies is used to determine the progress of
breast cancer, which is described in stages. The stage of breast cancer is defined in terms
of inspected tumor size, tumor grade, hormone receptor status, HER2/neu oncogene over
expression, and margins of resection. The TNM system is one of the most commonly
used staging systems, accepted by the International Union Against Cancer (UICC) and
the American Joint Committee on Cancer (AJCC). The system assesses tumors based on
their tumor size,
There are four stages of breast cancer as shown in Table 2.1 In stage 0, the cancer
is said to be in situ. That is, the cancer is only present at the site where it was first
detected and has not spread to other places in the body. A tumor is described as stage I if
it has spread beyond the margins into the surrounding tissue. A tumor is categorized as
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stage II if it is invasive between 2 and 5 centimeters and has spread from the original site
to other parts of the body. Stage III tumors have sizes greater than 5 centimeters. If a
cancerous tumor has grown into the chest wall or spread to lymph nodes, then it is
classified as stage IV. T category is another classification scheme used to indicate the
development of cancer. The two classification systems are similar as they both relate to
the size of the tumor. The chart below shows how the stage and T category relate.
Table 2.1: Physicians use staging to indicate the size and location of a patient's cancer.
The AJCC-TNM classification system is shown in the table above.

Stage

T category Tumor size ts (cm)

Description

0

T0

ts < 2

I

T1

ts < 2

II

T2

2 < ts <5

III

T3

ts > 5

IV

T4

ts > 0

Size of tumor is less than 2 centimeters in
diameter and is in situ.
Size of tumor is less than 2 centimeters in
diameter and has spread beyond margins.
Size of tumor is between 2 and 5 t
centimeters in diameter and has spread
beyond margins.
Size of tumor is greater than 5 centimeters
in diameter and has spread beyond
margins.
Tumor is any size, has attached to the
chest wall and spread to the pectoral
lymph nodes.

Treatment
A number of treatments are available for breast cancer including surgery,
radiation therapy, chemotherapy, hormonal therapy and immunotherapy. The kind of
treatment carried out basically depends on the stage of cancer. It is not uncommon for
more than one kind of treatment to be used in combination. There are two types of
surgical procedures, the lumpectomy and the mastectomy. In a lumpectomy, the tumor
and its surrounding tissue, the margin, is removed from the breast. The second kind of
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surgical procedure is the mastectomy, where the entire breast is removed. Lymph nodes
are also removed in a mastectomy to determine the stage of the disease more precisely.
As a precautionary measure, radiation therapy is usually recommended for invasive
cancers that have spread into the surrounding tissue in addition to lumpectomy or
mastectomy. Radiation therapy involves using high-powered X-rays to bombard the site
of the cancer. Radiation is intended to halt, or decrease the rate of growth, of a cancerous
tumor by denaturing the DNA of cells. Chemotherapy is another form of treatment that
uses cytotoxic, or cell killing, drugs to rid cancer from the body. In some cases it is
administered before surgery to reduce the size of the tumor. More often it is given after
surgery to help reduce the chances of the tumor reforming. Chemotherapy is responsible
for hair-loss during cancer treatments, although a common misperception is that hair loss
comes as a result of other forms of therapy.
Since breast cancer has been correlated with high levels of estrogen in the blood,
it is thought that decreasing estrogen levels can reduce the risk of recurring cancer. Thus
hormonal therapy is sometimes given after chemotherapy to patients in cases where
tumors have estrogen positive receptors, which are susceptible to hormone treatment.
Tumor cells are not attacked by the body's immune system since they are recognized as
the body's own cells and not as foreign antigens. Immunotherapy is a form of cancer
treatment that causes the immune system to respond to the tumor cells as if they were bad
cells, specifically targeting them for destruction. Indicators for all these kinds of therapy
are always changing. It has not been established which treatment works best. Many times
combinations of therapies are used.

11

Prognosis
A prognosis is a prediction that entails how a patient's disease may progress, their
expected chance for recovery and projected life expectancy post-diagnosis. The prognosis
is based on previous health records and response to treatments. The basis for a prognosis
is formed from statistics gathered from case studies on a particular disease. The accuracy
of a prognosis is based on the extent of research conducted and will also depend on the
experience and expertise of the physician(s) rendering the prognosis. Prognosis for
women with breast cancer generally declines as the stage progresses. The odds of a
woman living beyond 10 years after being diagnosed with breast cancer are roughly 95%,
88%, 66%, 36%, and 7% for stages 0, I, II, III, and IV respectively. It is important to
keep in mind, however, that a prognosis can never carry a predicted outcome for an
individual with 100% certainty, but knowing a prognosis can help physician make
informed decisions as to whether certain treatments are worthwhile, necessary, too
dangerous, etc. The prognosis plays an important role in end-of-life decisions.
Misdiagnosis in Breast Cancer Screening
The importance of breast cancer screenings should not be underestimated.
Increasing survival rates have been attributed to healthcare awareness campaigns and
improving medical technologies, particularly in the U.S. Regular examinations are key to
early detection; however, as with any examination, there exists the possibility of
misdiagnosis due to error. The goal is to reduce error as much as possible.
There are two categories of scientific error, systematic error and statistical error.
A systematic error is the difference between what has been computed, estimated or a
measured state of something and its actual state. A systematic error is not random; it
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arises from an unknown source and can be eliminated or resolved once the source is
identified. Human error is an example of systematic error that can be a factor in
misdiagnosis. Results can be mixed up or misinterpreted as the wrong type of breast
cancer resulting in a patient receiving the wrong type of treatment.
A statistical error is also the difference between what has been computed,
estimated or measured state of something and its actual state. However, statistical errors
are due to fluctuations in the measurement apparatus that are not predictable. Statistical
errors are further subdivided into type I errors and type II errors. A type I error is also
known as a false positive. As illustrated in the confusion matrix below, a false positive
occurs when a hypothesis states something is true when it is actually not true. An
example of this is when a patient receives a false alarm and is told she has cancer when
she in fact does not. Type II errors, also referred to as false negatives, occur when the
status of something is reported as false when it is actually true. An example of this is
when a malignant tumor is diagnosed as benign and the patient is told that she is clear of
cancer when she actually is not. The false negative is indicated in the upper right corner
of the confusion matrix below.
The performance of a diagnostic system is measured by its sensitivity and
specificity. Sensitivity is the measure of how reliable a system is at making positive
identifications, or, in other words, correctly identifying that which is inspected as being
specifically that which is sought. A highly sensitive system will recognize what it is
looking for most of the time, and rarely produce a false negative. Thus sensitivity is
expressed as the ratio of number of true positives, TP, to the sum of true positives and
false negatives as shown in the equation,
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Sensitivity =

TP
TP + FN

Eq. 1.1

Specificity is a measure of how well a system can make a negative identification,
or indicate when something inspected is not what is being sought, but something else. A
classification system with high specificity will rarely make the mistake of identifying
what is being inspected as what is being sought. Specificity is thus defined as the ratio of
the number of true negatives, TN, to the sum of true negatives and false positives as in
the equation,

Specificity =

TN
TN + FP

Eq. 1.2

Figure 2.3 displays a confusion matrix, which illustrates the four possible outcomes of an
evaluation. The results of a test performed with perfect sensitivity and specificity will all
be either TP or TN' and never FP or FN. In actuality, no inspection method or tool can
evaluate with perfect accuracy. Typically an instrument is considered to have acceptable
performance if its specificity and sensitivity are above 0.90.
In cases where cancers go undetected, or in other words, when a screening results
in a false negative (FN), adequate treatment can be delayed, allowing cancers to advance
to later stages where more drastic treatments may be required. More frequent
examinations may reduce the chances of missing a malignancy, but there are issues with
this as well. Apart from the financial aspect, (assuming cost is not a prohibitive factor,
although it is in some cases) the possibility of having a false positive (FP) result increases
with the number of screenings carried out.
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Figure 2.3: The confusion matrix. A "perfect" system detects with 100% sensitivity and
100% specificity. That is, it only makes true positives (TP's) and true negatives (TN's) in
green and never false positives (TP's) and false negatives (TN's) in red.
A study conducted by the Cancer Registry of Norway reported on Norwegian
women who started having mammograms bi-annually near age 50 and continued having
mammograms for 20 years had approximately a 1 in 5 chance of getting a false positive
result at some point during the 20 years.[5] Nevertheless, one may raise the question,
"Are the risks of getting a misdiagnosis worth having regularly scheduled examinations?"
The question is fair and important.
The pronouncement of cancer can be psychologically distressing. Perhaps even
more traumatic is the experience of needlessly enduring breast cancer treatments, which
are not completely harmless. Moreover, medical expenses can mount an unnecessary
financial burden on the patient that they might not be able to recoup. Misdiagnosis also
encumbers healthcare systems with malpractice lawsuits that adversely affect health care
providers, their services, and ultimately the patients.
The Norwegian study found that although 1 out of 5 women have false positive
exams, only 93.8% of their follow-up biopsies returned true positive results for cancer.
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Thus, the study concluded that regular breast cancer screenings are advisable despite the
odds of misdiagnosis. Nevertheless, the aim in breast cancer screening is to perform
diagnoses keeping the odds of missed and false detections to a minimum. In Chapter 3 we
discuss the role technology plays in mammography.
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CHAPTER 3 – DIGITAL MAMMOGRAPHY
Film Mammography, Digital Mammography and Computer-Aided Systems
Mammography and the quality of overall healthcare can be improved by
technology to a great extent. Film mammography and digital mammography are
concurrent technologies used for detecting breast cancer. Film mammography also,
known as traditional mammography, is the conventional method that stores x-ray images
on film as described earlier. Digital mammography developed subsequently with
advances in computer technology and optical electronics. Digital mammography involves
producing X-ray images of the breast and storing them directly to a machine in electronic
form. Each has its own advantages and disadvantages, which will be described in more
detail later. However, one of the advantages in digital mammography is that mammogram
images can be analyzed and manipulated using computer-aided diagnostics, or CAD.
CAD systems aid radiologists in locating malignancies in digital mammograms. They
were first put to use in the 1990's, and they continue to develop with increasing promises
to benefit the field of clinical mammography.
Industrial research is primarily responsible for many of the advances seen in
digital mammography. At present, the only CAD system approved by the Food and Drug
Administration (FDA) for use in screening, diagnostic and digital mammography is
ImageChecker® manufactured by R2 Technology Inc. in Los Altos, CA. ImageChecker®
was the first CAD system approved by the FDA in 1998. Since then it has been installed
in more than 1400 clinical sites worldwide. Two other CAD systems that have also been
approved by the FDA are Second Look™

by CADx Medical Systems, Inc. in

Northborough, MA and the MammoReader™ by Intelligent Systems Software, Inc.
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Clearwater, FL. CADx Medical Systems merged with another company called Qualia
Computing, Inc. in 2002, shortly after receiving FDA approval. However R2 Technology
sued CADx that same year for infringing on three of its patents. CADx lost the lawsuit
and is no longer in operation. It appears Intelligent System Software, Inc. was not
successful in establishing a foothold in the industry after its MammoReader™ was
accepted by the FDA in 2002. Thus R2 Technology Inc. remains standing as the sole
industry force leading the development of technology in the area of digital
mammography.
Academic research also plays a significant role in the development of digital
mammography and CAD systems. A group in the radiology department at the University
of Chicago was one of the first to bring computer-assisted diagnostics into the clinical
arena. In January 2005, R2 Technology and the University of Chicago Medical Center
announced their exclusive agreement to collaborate on the development of a
mammographic CAD workstation reference library. The multi-faceted collaboration is
looking into a number of different aspects involving mammography including: image
processing, image storage, CAD mark interpretation and recall through PACS (Picture
Archiving Interface) and DICOM (Digital Imaging and Communications in Medicine)
connectivity. [6]
The eDiamond project is a joint effort headed by Oxford University and supported
by IBM, Hurley and the UK government. The aim of the project is to use grid computing
to facilitate information distribution among health centers in the UK. The hope is to
relieve a burdened healthcare system experiencing a shortage of radiologists along with
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an increasing patient population and improve the reliability of the diagnoses using the
redundant systems engineering concept.[7]
The University of California at San Diego (UCSD) is one of 38 centers in the
United States to hold a National Cancer Institute designation as a Comprehensive Cancer
Center. The university has several well-established programs involved in cancer research
and is expanding. As of the spring 2005, digital mammography machines have been
installed at two UCSD locations, the Rebecca and John Moores Cancer Center and the
UCSD’s Breast Imaging Center in Hillcrest. The research there is promising to have far
reaching impact on the San Diego community and beyond.[8]
Louisiana State University (LSU) serves as home base for UniPACS (Universal
Picture Archiving and Communication Systems). UniPACS is a software company
focused in medical imaging and staffed with LSU researchers headed by Dr. John M.
Tyler—former CEO and president, now vice-president of the company and professor
emeritus of the computer science department at LSU. The company offers a suite of
applications that allow medical images to be archived and shared securely via the
Internet. The company's products are used in several health care centers in the southeast
and New England area. They save cost, eliminating the need for expensive equipment
previously required by radiologists for viewing the images.
Sample and Tyler CAD System
Although a CAD package from UniPACS is not yet available for commercial use,
Professor Tyler has performed extensive academic research in digital medical image
processing. He has developed a CAD system with one of his former doctoral students,
Dr. John Sample.
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Sample's dissertation, entitled "Computer Assisted Screening of Digital
Mammogram Images", sought to address the needs of CAD systems designed for digital
mammography. In the thesis, Sample describes a computer-aided detection system
comprised of algorithms he designed with Tyler to identify and outline suspected
cancerous masses in digital mammograms. The system is self-testing and also performs
comparative analyses of its results.9
The Sample-Tyler CAD system displays excellent performance in identifying
malignant tumors. Their algorithm detects masses with a sensitivity ranging from 92.8%
to 100%. However, Sample reports in his thesis that it also misclassifies an unacceptable
proportion of non-cancerous masses as malignant. Thus the specificity of the algorithm is
undesirably low. In the closing statements of his thesis he proposes developing a postprocessing algorithm to help further discriminate between malignant masses and benign
masses.
Shape Analysis System
Tyler suggests that tumor shape can be used as a discriminating factor. The shape
analysis system presented here is an algorithm designed to geometrically classify the
shapes of tumors identified in mammograms by the Sample-Tyler CAD system. This
shape classification scheme involves approximating tumor shapes with ellipses and then
categorizing the shapes of the ellipses based on their parameters: size, eccentricity, and
goodness of fit. The elliptical parameters are then compared with diagnostic data for each
tumor to determine correlations between tumor shape in order to identify and discard
false positive verdicts rendered by the Sample-Tyler CAD system. The Sample-Tyler
CAD system and shape analysis system will be discussed in Chapter 4 in greater detail.
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CHAPTER 4 – TUMOR SHAPE ANALYSIS
Introduction
The purpose of a computer-aided diagnostic (CAD) system in digital
mammography is to aid radiologists in identifying possibly malignant tumors in digital
mammograms using computer algorithms. As stated in Chapter 3, all such systems are
subject to statistical error. In this work we aim to improve the performance of a CAD
system developed by Tyler and Sample by increasing its specificity using tumor shape
analysis and categorization.
Tumor Shape Analysis Premise and Methodology
The approach to tumor shape analysis presented here involves approximating the
shapes of tumors by fitting them with ellipses and then categorizing the tumors based on
the dimensions of the ellipses and the closeness of the approximation. We propose that
tumors warranting investigation are localized, globular masses (as opposed to say stringy
objects or objects with highly irregular, concave, or angular features). Thus, the shapes of
these masses projected onto two-dimensional images would appear round or near circular
when segmented apart from the rest of the image.
The Sample-Tyler algorithm performs graphical segmentation of the digital
mammogram images. The images of the tumors it segments appear in a variety of shapes.
Referring to the assumption that tumors suggested for biopsy tend to be round to some
degree, and have edges that form closed curves, the tumor shape algorithm is intended to
be used to define a criterion by which false positives generated by the Sample-Tyler CAD
system can be identified based on shape. We refer to the tumor shape-fitting algorithm as
the Ellipse-Closed Curve Fitting (ECCF) system. The ECCF is comprised of an algorithm
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that performs edge detection on the overlay images produced by the Sample-Tyler CAD
system and then attempts to fit an elliptical curve to the shape of the tumor in a way that
is similar to regression techniques used in statistics where a simple equation is
parameterized to fit a set of real data points. In fact, we adapt a regression analysis
technique (R-square) to measure the closeness of the fit as well as other structural
quantities. The output of the ECCF is in the form of text and graphic images that show
processing of the images step-by-step. The tumor shape algorithm can then be used postoperatively to the Sample-Tyler CAD system to analyze tumors based on shape and then
reject shapes that do not match the derived criteria. The aim is to increase the specificity
of the overall detection process.
Elliptical Quantities
Since the structural analysis of the ECCF system is based on elliptical quantities,
we briefly discuss the two elliptical quantities we consider, which are area and
eccentricity. Any 2D ellipse can be completely described given its area and the ratio
between its major and minor axes. The area of an ellipse is given as π times the product
of its semi-major axis and its semi minor axis as shown in equation 4.1, where a and b are
the major axis and minor axis respectively.
A = πab

Eq. 4.1

The eccentricity is a measure of how round or needle-shaped an ellipse is. Here we
denote eccentricity as e and show how it is defined in terms of the semi-major and minor
axis.
⎛ a2
e = ⎜⎜1 − 2
⎝ b

1

⎞2
⎟⎟
⎠
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Eq. 4.2

For a circle, the major and minor axes are equal lengths. If the major and minor axes are
the same length, then the quotient

a2
is 1, subtracted from 1 gives zero. Thus, a circle
b2

has zero eccentricity. As an ellipse becomes more needle-shaped the minor axes length of
an ellipse a approaches zero and the eccentricity e approaches 1. By approximating the
shapes of tumors with ellipses, the ECCF system can then use the area and eccentricity of
the ellipses to quantify tumor shape.
MATLAB Implementation
The shape analysis algorithm was implemented in MATLAB. MATLAB has a
number of capabilities that make it suitable for digital image processing. The MATLAB
application operates on a variety of platforms: DEC Alpha, HP 9000, IBM RS/6000, PC
& MAC, Open VMS, SGI (Silicon Graphics), and SUN Sparc. All diagnostics presented
in this thesis research were implemented in MATLAB and performed on a PC equipped
with a 1.6 GHz- Intel Pentium processor and 512 MB of RAM. MATLAB's built-in I/O
functions support a number of video, text, audio and image formats including JPEG, PNG
and TIFF. The medical images are in a format using Lossless-JPEG compression or
LJPEG. The LJPEG format is not supported by MATLAB; however, the images are
converted from LJPEG format to TIFF format as described in Appendix A. The TIFF
images are then read into MATLAB. In MATLAB, images are represented as twodimensional matrices allowing low-level image analysis and manipulation using
MATLAB's efficient matrix and vector computations. MATLAB also has graphics and
visualization capabilities that make useful for rendering scientific and engineering
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graphics quickly and easily. Lastly, MATLAB is programmable; it has a mathematical
scripting language, which we have used to implement an automated shape analysis
system that takes advantage of the functions and features just described.
Overview Sample Tyler CAD System
The Sample-Tyler CAD system is designed to detect regions in digital
mammograms that may possibly be tumors. The digital mammograms for this work are
taken from actual patient cases stored in the DDSM (Digital Database for Screening
Mammography

(DDSM),

at

the

University

of

South

Florida)

(http://marathon.csee.usf.edu/Mammography/Database.html). The digital mammograms
have already been classified as normal, cancerous or benign. Sample and Tyler used the
database as a test bed for their CAD system. The system is quite accurate. It performs
with sensitivity above 0.928 (or 92.8%). However, it returns an average of 36.6 FP's per
image, which is undesirable. So the goal is to develop an algorithm that reduces the
number of false positives it detects to increase the CAD systems specificity.
Figure 4.1 shows a flow diagram of the Sample-Tyler CAD system. Input patient
cases are represented on the left by the numbered by panes. Each pane contains a set of 4
digital mammogram images belonging to one patient. There are two views for each
breast: left medial lateral oblique (L-MLO), right medial lateral oblique (R-MLO), left
cranial caudal (L-CC), right cranial caudal (R-CC). The Sample-Tyler CAD system,
represented at the center of the diagram, processes the digital mammograms and
generates output shown in the green and yellow areas on the right:
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Figure 4.1: Schematic of the Sample-Tyler CAD system (center). The algorithm takes
digital mammograms from patient cases as input, displayed as numbered panes on the left
and produces images containing areas where suspected cancerous tumors have been
marked.
1. Four text files (represented in the green area of the diagram). Each file
contains one integer indicating the number of suspected areas in the breast
detected by the algorithm for each mammographic view. NL-MLO, NR-MLO,
NL-CC, and NR-CC represent the integers in each text file corresponding to
left medial lateral oblique, right medial lateral oblique, left cranial caudal,
right cranial caudal view respectively.
2. Four sets of images (represented in the yellow area of the diagram).
Each set of images corresponds to a different mammographic view: left
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MLO, right MLO, left CC, right CC. The number of images in each set
depends on the number of cancers detected for each mammography view.
Each image contains a single detection indicated here by the red dot.
To conserve disk space, the images are reduced in color depth to 1-bit (stored in
monochrome black and white) as well as reduced in width and height (maintaining the
aspect ratio of the original digital mammogram image it was taken from).
Overview of Ellipse-Closed Curve Fitting (Extending the Sample-Tyler CAD
system)
The shapes of the tumors detected by the Sample-Tyler CAD system have various
multi-diametered shapes the outlines of which are closed curves. As stated earlier in the
premise, we suspect true positive tumors are more likely to have round or elliptical
shapes. The ellipse-closed curve fitting (ECCF) system was developed to serve as a postscreening component to perform shape analysis on the overlay images generated by the
Sample-Tyler CAD system. The ECCF system is comprised of several sub-components,
represented in the blue rectangle in Figure 4.2. The subcomponents are organized in the
diagram in three divisions: pre-processing, curve-fitting, and fit evaluation. Overlay
images from Sample-Tyler system, framed in yellow borders, enter the ECCF system as
indicated by the red arrow. Each sub-component performs a particular operation on the
overlay images. The green arrows point to the output of the ECCF system. The item in
the top right corner represents an ASCII file generated by the ECCF system, which
contains several columns of data calculated by the ECCF system- including the ratio
between the areas of the tumor and the ellipse that has been fitted to it, the eccentricity of
the fitted ellipse and the R-square of the regression. Each of these subcomponents will be
discussed in more detail in the following sections.
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Figure 4.2: Schematic of ECCF system (Ellipse-Closed-Curve Fitting) system. The ECCF
computes in three phases pre processing, where the images are cropped and edgedetected, curve-fitting, where the shapes of the tumor are fitted by ellipses and fitevaluation, where that goodness of the fit is calculated and performance information is
output.
Pre-formatting
Image cropping
The overlay images are initially generated with the same size and aspect ratio
(length-to-width) of the digital mammogram it is created from. These images are
relatively large, ~4000 × ~4000 pixels. One image alone can have a file size of 30-40
MB. Thus the images are cropped for the sake of efficiency. Figure 4.3 shows an actual
left mediolateral mammogram, outlined by a blue border, where the tumors detected by
the Sample-Tyler have been marked in red. The dotted white arrows show how each
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tumor detected appears in a separate overlay file, framed in yellow. The areas marking
the tumors are typically a small fraction of the overlay image area ~3% of the entire
image. The images are cropped relieving all but a 20-pixel buffer on each side of the
tumors. The cropped images, framed in green, can be processed with much greater
efficiency as the search space has been reduced.

1)

Cropped
Images

2)

3)

Overlay
Images

Digital Mammogram
(Left Mediolateral)

Figure 4.3: Digital mammogram of the left breast mediolateral view is shown outlined by
blue rectangle. Detected tumors indicated in red are shown in overlay images outlined by
yellow rectangles. Cropped images are shown in green frames. The tumors are numbered
1, 2, and 3 for future reference.
Edge detection
Only pixels defining the shape of the tumor are of interest. The algorithms used to
approximate tumor shape operate only the pixels lying on the edge of the tumors. All
pixels inside the edge boundary must be removed. Thus, after cropping, the next
operation performed is edge detection.
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The edges in an image can be found by computing the Laplacian on that image.
An image can be represented as a two dimensional surface I ( x, y ) , where I ( x, y )
represents pixel intensity and (x,y) are pixel coordinates. Edges in the image exist in
places where the intensity of the pixels is varying. More precisely, edges exist where the
partial derivate

∂I ( x, y )
∂I ( x, y )
is not equal to zero. Thus edges detected can be
or
∂x
∂y

detected by computing the derivative of I ( x, y ) with respect to x and y or the gradient of
I ( x, y ) , ∇ I ( x, y ) =

∂I ( x, y ) ∂I ( x, y )
. The gradient will have negative or positive values
+
∂x
∂y

at edges, but the absolute value of the gradient is the only thing of interest. We take the
dot product of ∇I ( x, y ) with itself. Thus the edge-detected images are essentially the
Laplacian of the original image I ( x, y ) , ∇ 2 I ( x, y ) .
The creation of elementary and specialized arrays and matrices as well as basic
array operators and operations are provided in MATLAB. Since digital images are
represented in MATLAB as two-dimensional matrices, basic linear algebra operations
and manipulations can be performed on them including: addition, subtraction,
multiplication, transposing, left/right divide and others. We construct a gradient operator
from these simple linear algebra operations in MATLAB to perform edge detection on
images. We compute the Laplacian using discrete derivatives.

∇ 2 I = ∇I ⋅ ∇I ≈ ΔI e ⋅ ΔI e
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Eq. 4.3

where,

ΔI e = ΔI u + ΔI d + ΔI r + ΔI l

Eq. 4.4

ΔI u = I − Sm I

Eq. 4.5

ΔI d = I − SmT I

Eq. 4.6

ΔI r = I − ISn

Eq. 4.7

ΔI l = I − ISnT

Eq. 4.8

∆Iu, ∆Id, ∆Ir, and ∆Il, are matrices containing the values of the discrete differences
between adjacent pixels in the "up", "down", "left" and "right" directions respectively.
Superscript, T, indicates a transposed matrix. The variables m and n are the dimensions
of the image I ( x, y ) . Sm and Sn are circular permutation matrices described in more detail
in Appendix C. Figure 4.4 shows an example of the three images of the cropped tumors,
from Figure 4.3, in relation to the edge detected images.
Ellipse Closed Curve Fitting

The next section entails descriptions of the ECCF subcomponent, which actually
fits ellipses to the closed-curve outlines of the tumors. The basic objective here is to
calculate parameters for ellipses that match the location, shape, and size of the tumors as
closely as possible. First, since the tumor shape is actually a constellation of points, we
must describe the location of the tumor in a way that is non-arbitrary. We require that the
center of the ellipse be fitted to the tumor and the center of the tumor itself must coincide.
So we have to find the center of the tumor. We do that by calculating its centroid.
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1)

2)

3)

a)

b)

Figure 4.4: Example of tumors detected by the Sample-Tyler CAD are shown in a). Red
arrows relate corresponding edge-detected images in b) as rendered edged-detecting
component of the shape analysis algorithm.
Centroid calculation

The Cartesian coordinates of a centroid are the means of the coordinates of the set
of vertices. Figure 4.5 contains a simple illustration of the centroid corresponding to a set
of three points Pi, where i = 1,2,3 .
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Figure 4.5: Calculating the centriod, C (xc,yc), for three points P1 ( x1 , y1 ) , P2 ( x 2 , y 2 ) ,
and P3 ( x 3 , y 3 )
If the three vertices are located at P1 ( x1 , y1 ) , P2 ( x 2 , y 2 ) , and P3 ( x 3 , y 3 ) then the centroid
is a point C ( x c , y c ) at which,
xc =

x1 + x2 + x3
3

Eq. 4.9

yc =

y1 + y2 + y3
3

Eq. 4.10

In general, for any number of points N, the centroid is calculated as shown in the
following equation:
Eq. 4.11

N

xc = x =

∑m x
i =1
N

i i

∑m

i

i =1

Eq. 4.12

N

yc = y =

∑m y
i =1
N

i

i

∑m
i =1

i

, where mi is a weighting factor generalizing the expression to apply to non-uniform
systems. In this case all pixels are identical, mi = m ≠ 0 . Thus, all the weights factor out
of the expression.
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The vertices Pi ( x i , y i ) are the coordinates of the pixels forming the shape of
tumor. C ( x c , y c ) represents the location of the tumor and serves as a unique and nonarbitrary point of origin for constructing the fitted ellipse.
Mapping Cartesian coordinates to polar coordinates

With the centroid serving as a reference position for the tumor, we now seek to
match the size, shape, and orientation of the tumor shape with an ellipse as closely as
possible. Just as in linear regression, where the objective is to find the linear equation that
comes closest to fitting a collection of data points, we wish to find the equation for an
ellipse that comes closest to fitting a constellation of points lying on a closed curve.
To begin, our method requires a special mapping of the points on a Cartesian
plane to a polar coordinate plane. The mapping is a bijection. All points Pi ( x i , y i ) get
r
mapped to exactly one point Ri (θ i )
r
Pi ( x i , y i ) → Ri (θ i )

Eq. 4.13

Figure 4.6a illustrates points Pi ( x i , y i ) on a Cartesian plane as well as their centroid. The
r
function Ri (θ i ) is obtained by calculating the vector that extends from the centroid

C ( x c , y c ) to each point Pi ( x i , y i ) . The corresponding angles, θ i are computed as,
⎛
θ i = arccos⎜⎜
⎜
⎝

r
Ri ⋅ xˆ
r
Ri ⋅ xˆ

⎞
⎟,
⎟⎟
⎠

Eq. 4.14

where x̂ is the unit vector appearing in Figure 4.6a. The arccosine is one-to-one, but not
onto. Two points bisected by the horizontal axis x̂ and equidistant from the vertical axis
ŷ would have the same angle, even though they are in different half planes. The problem
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r
is circumvented by introducing an asymmetry where the points, Ri (θ i ) , in the lower half
r
plane are phase shifted by 180˚. After that, Ri (θ i ) is sorted to obtain a function that

describes tumor shape as a radial function of theta exampled in Figure 4.6b.

a)

b)

Figure 4.6: Cartesian-Polar coordinate mapping. Three points, P1 ( x1i , y1 ) , P2i ( x 2i , y 2 ) ,
and P3i ( x 3i , y 3i ) in a) are expressed as a radial distribution in polar coordinates in b).
r
Both representations Pi ( x i , y i ) and Ri (θ i ) are used to obtain the metrics calculated to

fits ellipses to tumor shape.
As stated in the previous section, an ellipse can be completely described in terms
of its major axis, minor axis, orientation and position. We have to some how extract these
quantities from our point constellation.
First, a major axis and orientation for the ellipse is chosen large enough to extend
over the entire tumor shape, from end-to-end. This is accomplished by calculating a
r
vector v major between points on the tumor that are farthest apart as expressed in the

equation,
34

r
v major = max( Pi ( x i , y i ) − Pj (x j , y j ) )

Eq. 4.15

r
The norm of v major serves as the length of the major axis of the fitted ellipse. The angle
r
v major makes with the horizontal axis x̂ , is used to compute θ υ , which is used for the
orientation of the ellipse as:
⎛
θ υ = arccos⎜
⎜
⎝

r
v major ⋅ xˆ ⎞⎟
r
v major ⋅ xˆ ⎟⎠

Eq. 4.16

r
We compute the semi-minor axis for the fitted ellipse by finding min Ri (θ i ) as
r
shown in Figure 4.7 b. In reference to the tumor shape, the point min Ri (θ i ) is the point
on the edge of the tumor that is closest to the centroid.

a)

b)

r
Figure 4.7: a) The major axis of the fitted ellipse, v major , outlined in yellow, is computed

by finding the longest distance between two points Pi ( x i , y i ) and Pj (x j , y j ). b) The
r
minor axis of the fitted ellipse, v min or , also outlined in yellow, is computed as the
r
minimum of the function Ri (θ i ) .
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Constructing the fitting ellipse

With the major axis, the semi-minor axis, the position and orientation for the
fitted ellipse obtained; the images of the fitted ellipses are generated using:
⎡ xi ⎤
r r ⎡ cos θ υ
[
]
=
ℜ
⋅
+C =⎢
υ
⎢y ⎥
⎣ i⎦
⎣− sin θ υ

sin θ υ ⎤ ⎡υ major ⋅ cos(i )⎤ ⎡ x c ⎤
+
cos θ υ ⎥⎦ ⎢⎣υ min or ⋅ sin (i )⎥⎦ ⎢⎣ y c ⎥⎦

Eq. 4.17

r
′
The ellipses are constructed as a set of points Pi ( x i , y i ) from the vector υ . The variable
r
i is a real number varying from 0˚ to 360˚ in adjustable discrete steps. The vector υ

consists of the parametric equations for which the major axis is chosen to extend across
the horizontal axis of the image plane and the minor axis to align with the vertical axis of
′
the image plane. The orientation of the ellipse is set by rotating the points Pi ( x i , y i ) in

the plane about the center of the ellipse by θ υ as specified in the matrix ℜ . The fitting
r
ellipse is the shifted by the vector C ( x c , y c ) so that its center coincides with the centroid

of the tumor.
Fit Evaluation

The last subcomponent of the ECCF system measures how closely a fitting ellipse
matches the shape of a tumor. We perform three calculations to assess how the ECCF
system has performed: area match ratio, R2 or the coefficient of determination (adapted
from statistics), and a shape conformity value. These quantities will be discussed in more
detail in the following sections.
Area matching

Area matching is one of comparing the sizes of the tumor to the ellipse that has
been fitted to it. The area of the ellipse is computed directly from the equation:
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Afittedellipse =

πba

Eq. 4.18

2

The area of the tumor is computed by counting the number of pixels in the image. It is
simply the number of white pixels in the original overlay image.
Eq. 4.19

m⋅n

Atumor = ∑ I ( x, y )
i

where I ( x, y ) = 1 if the pixel is white and I ( x, y ) = 0 if the pixel is black. When the ratio
between Afitted ellipse and Atumor is close to 1, it is an indicator that the tumors are close in
area or size. The area match ratio is a rough indicator of the closeness of the fit.
R-square (coefficient of determination)

In statistics, the coefficient of determination R2 is the proportion of a sample
variance of a response variable that is "explained" by the predictor (explanatory)
variables when a linear regression is done. It is used as a quantitative measure of the
"goodness of fit" of linear data. R2 is a descriptive measure between 0 and 1. The closer it
is to one, the better the fit. The ECCF technique involves fitting the parametric and
canonical equations of ellipses to real data points. We adapt R2 from statistics and use it
as a means of more precisely measuring how well fitted ellipses have matched the shape
of the tumor. We use quantity R2 as defined in Equation 4.20,
N

R 2 ( X ,Y ) =

cov( X , Y )
=
std ( X ) std (Y )

⎛

∑ ⎜⎜ X
i

N

⎛

i

⎝

⎝

∑ ⎜⎜ X

i

−

i

−

Eq.

⎞ ⎞⎛
1⎛ N
1 ⎛ N ⎞⎞
⎜ ∑ X j ⎟ ⎟⎜ Yi − ⎜ ∑ Y j ⎟ ⎟
⎟ ⎟⎜
⎟⎟
N ⎜⎝ j
N ⎜⎝ j
⎠ ⎠⎝
⎠⎠

⎞⎞
1⎛ N
⎜∑ X j ⎟⎟
⎟⎟
N ⎜⎝ j
⎠⎠
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2

N

⎛

i

⎝

∑ ⎜⎜ Y

i

−

⎞⎞
1⎛ N
⎜ ∑Y j ⎟⎟
⎟⎟
N ⎜⎝ j
⎠⎠

4.20
2

, where the terms Xi are the target values set and Yi fitted. We adapt the quantity Rsquare for our purposes as shown in Equation 4.21.
⎛
1⎛ N
⎜
X
−
∑i ⎜ θi N ⎜⎜ ∑j X θ ji
⎝
⎝
N

R 2 ( X ,Y ) =

cov( X θi , Y (θ i ))
std ( X θi ) std (Y (θ i ))

=

⎛
1⎛ N
⎜
X
−
∑i ⎜ θi N ⎜⎜ ∑j X θ j
⎝
⎝
N

⎞⎞
⎟⎟
⎟⎟
⎠⎠

2

Eq.

⎞ ⎞⎛
⎞⎞
1⎛ N
⎟ ⎟⎜ Y (θ i ) − ⎜ ∑ Y (θ j ) ⎟ ⎟
⎟ ⎟⎜
⎟⎟
⎜
N⎝ j
⎠ ⎠⎝
⎠⎠
⎛
⎞⎞
1⎛ N
⎜
⎜
Y
(
θ
)
Y
(
θ
)
−
∑i ⎜ i N ⎜ ∑j j ⎟⎟ ⎟⎟
⎠⎠
⎝
⎝
N

4.21
2

here X θi and Y (θ i ) are θ i is the dependent variable for corresponding profiles of the
target and the fitted ellipse respectively. The independent variable Y (θ i ) is taken from a
continuous function, the radial coordinate of the fitted ellipse given by,
Y (θ i ) = x ′ 2 + y ′ 2

⎡ x'⎤ ⎡ cos φ
⎢ y '⎥ = ⎢− sin φ
⎣ ⎦ ⎣

sin φ ⎤ ⎡ x ⎤
cos φ ⎥⎦ ⎢⎣ y ⎥⎦

Eq. 4.22

Eq. 4.23

x and y are obtained from the parametric equation for and ellipse

x = a cos(θ i )

Eq. 4.24

y = a sin(θ i )
By using R2 we obtain how the approximating function Y (θ i ) varies with our target
function X θi .
Ellipse shape conformity value

The ellipse shape conformity is another value we calculate to assess the
"goodness of fit.” It is a unit of pixel length, in this case pixel length, and is calculated as
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′
the average of deviations of the points of the fitted ellipse Pi ( x i , y i ) from the tumor

shape Pi ( x i , y i ) as shown in Equation 4.23 and illustrated on Figure 4.8.
N

∑ min P (x , y ) − P ′ (x , y )
i

i

i

i

i

Eq. 4.25

i

i

N
Figure 4.8 shows a schematic of how the ellipse shape conformity is calculated.
The fitted ellipse is shown in red. The shape of the tumor is represented by the point set
Pi connected by blue lines. The center of the ellipse and centroid of the tumor are
positioned to coincide. The smaller the ellipse shape conformity value, the closer the
fitted ellipse is to the shape of the target. An ellipse shape conformity value equal to zero
means the target has an identical shape as the ellipse. The higher the ellipse shape
conformity value, the more dissimilar the target shape is from the fitted ellipse. The
shape conformity coefficient calculated for two identical shapes would be zero.
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Figure 4.8: The ellipse shape conformity value is calculated by comparing the shapes of
the tumor and the ellipse that has been fitted to it by the ECCF system. The fitted ellipse
is represented in red. The set of points connected by blue lines represent the edge of the
tumor. The green lines represent the amount of error between the two shapes.
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CHAPTER 5 – RESULTS AND CONCLUSION

The ECCF system was tested on a battery of test images and then actual tumors
generated by the Sample-Tyler CAD system. The battery of test images consisted of
ellipses of various sizes, eccentricities and orientations generated by a testing program
and is organized into four sets in Appendix B. Set 1 contains images of an ellipse with a
semi-major axis of 100 pixels, a semi-minor axis of 50 pixels, rotated through 180° in
steps of 15°. Set 2 contains test images with vertical ellipses at various eccentricities
where the semi-major axis length is maintained at 100 pixels. Set 3 contains test images
with horizontal ellipses at various eccentricities where the semi-major axis length is also
maintained at 100 pixels. Tests on ellipses varying in size, with equal major and minor
axes, appear in Set 4. An example of one test result for an ellipse with a semi-major axis
of 100 pixels, semi-minor axis of 50 pixels, orientated at 105° off the horizontal axis
appears in Figure 5.1. The original test image generated initially by the graphics routine
is shown in part A. Part B shows the edge-detected test image. In part C, the radial
function r(θ) of the ellipse with respect to its center is plotted in blue. A fitted ellipse is
drawn from the major and minor axes computed by the component algorithms of the
ECCF system. The radial functions, r(θ), of the original ellipse and its fitted ellipse are
plotted together for comparison in blue and red respectively in part D. Part E shows the
actual 2D image of the fitted ellipse alone. Part F shows the fitted ellipse (red) plotted
over the original ellipse (blue) for comparison. The white pixels indicate where the points
of the fitted and original ellipse match exactly.
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a)

b)

c)

d)

e)

f)

Calculated quantities - ellipse_angle_at_15.tif
101.5012
Semi-major axis (pxw)
49.8448
Semi-minor axis (pxw)
103.9678
Angle
1.589427e+004
Area of Fitted Ellipse
16014.0000
Area of tumor (px)
0.9925
Ratio of difference in area
0.8711
Eccentricity
9.596332e-001
Shape conformity (pxw)
0.9985
R-squared

Figure 5.1: Output from the ECCF system for an ellipse with 100 pixel semi-major axis
and 50 pixel semi minor axis at an angle of 105° off the horizontal axis. The elliptical
quantities calculated are in close agreement with the actual dimensional parameters of the
ellipse. The shape conformity is very good, slightly less than one pixel. The R2
calculation also indicates close agreement.
The ECCF system performs satisfactorily for the test images. Figures 5.2, 5.3 and
5.4 are demonstrations of the ECCF system output for actual tumor overlay images
generated by the Sample-Tyler CAD system which have arbitrary shapes.
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a)

c)

b)

4.1496

d)

e)

f)

16.0078
4.1496
104.4703
208.6852
263.0000
0.7697
0.9658
1.0129
0.9017

Semi-major axis (pxw)
Semi-minor axis (pxw)
Angle
Area of Fitted Ellipse
Area of tumor (px)
Ratio of difference in area
Eccentricity
Shape conformity (pxw)
R-squared

Figure 5.2: Output data from the ECCF system for tumor shape 1. The original tumor
image appears in a). Part b) show the tumor after edge-detection. The radial distribution
function r (θ ) is plotted in c). The vertical axis is in units of pixel length. The minor axis
for the fitted ellipse is obtained from the absolute minimum of r (θ ) which is 4.149
pixels. Tumor shape 1 is more elliptical in comparison to the tumor shape 2 and 3. This is
reflected in the peaks appearing at close to 90˚ and 270˚. d) Shows the radial functions
for the tumor and its fitted ellipse are in fairly closed agreement. A 2D image of the fitted
ellipse is shown in e). f) shows an overlaying comparison of the fitted ellipse (red) with
the outline of the tumor in (blue). The white pixels indicate exact overlap.
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a)

c)

b)

5.13

d)

e)

f)

8.5440
5.1330
20.5560
137.7800
147.0000
0.9352
0.7994
0.7877
0.3497

Semi-major axis (pxw)
Semi-minor axis (pxw)
Angle
Area of Fitted Ellipse
Area of tumor (px)
Ratio of difference in area
Eccentricity
Shape conformity (pxw)
R-squared

Figure 5.3: Output data from the ECCF system for tumor shape 2. The original tumor
image appears in a). Part b) show the tumor after edge-detection. The radial distribution
function r (θ ) is plotted in c). Tumor 2 is almost round as r (θ ) fluctuate remains roughly
a radius of 7 pixels. The minor axis for the fitted ellipse is obtained from the absolute
minimum of r (θ ) which is 5.13 pixels. d) Shows the radial functions for the tumor and
its fitted ellipse are in fairly closed agreement. The agreement also bears out in e) and f).
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a)

c)

b)

4.2665

d)

e)

f)

6.8007
4.2665
107.1027
91.1546
100.0000
0.9075
0.7787
0.7524
0.1989

Semi-major axis (pxw)
Semi-minor axis (pxw)
Angle
Area of Fitted Ellipse
Area of tumor (px)
Ratio of difference in area
Eccentricity
Shape conformity (pxw)
R-squared

Figure 5.4: Output data from the ECCF system for tumor shape 3. Tumor 3 is also close
to round. Its radial distribution is almost flat- similar to tumor 2. It is however slightly
smaller than tumor 2 with a radius of roughly 5.5 pixels. The shortest radii in the r (θ ) is
shown to be 4.26 pixels in c). The shape conformity value reflects the agreement shown
in d), e) and f).
The purpose of the ECCF system is not intended to test for perfect roundness, as
perfectly elliptical shapes are not of interest. It is intended to extract objective numerical
information from arbitrary shapes for the purpose of data mining. The quantities for
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tumor area and eccentricity will always be approximate. R2 and the shape conformity
value can be used to indicate the amount a shape deviates from that of a fitted ellipse. We
suspect that tumors that fall within some volume, or volumes, in the space spanned by the
quantities we calculate and that the ECCF system may be trained to determine such
volumes given data sets of significant size consisting of tumors with labeled pathologies.
Future work would entail the construction and analysis of such data sets.
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APPENDIX A - LJPEG-TO-TIFF CONVERSION
The images we use from the Digital Database for Screening Mammography
(DDSM) at the University of South Florida are stored in a Lossless JPEG image formatLJPEG. This document is a guide for converting LJPEG images from the DDSM at USF
into the TIFF image format readable by MATLAB. JPEG is an image compression
format commonly used to reduce the file sizes of images typically for use on the web.
The JPEG compression scheme is lossy, that is, information is discarded from images
during compression in order to obtain smaller image file sizes. The result is a significant
reduction in file size accompanied by a reduction in image quality, which is however
hardly noticeable to the human eye depending on the amount of compression performed
on the image.
The LJPEG format is a lossless compression scheme as it results in no loss of
image information. It is typically used in medical, military and space imaging, high-end
film, professional studio-quality photography, and industrial machine vision systems.
This documentation is written for the specific purpose of converting LJPEG
images from the Digital Database for Screening Mammography (DDSM), at the
University of South Florida, to TIFF for use in MATLAB. It’s detailed step-by-step to
supplement Micheal Heath’s documentation, so that one can get up and running quickly
and easily.
A table summarizing the contents of the database can be found at
http://marathon.csee.usf.edu/Mammography/Database.html
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Installation/Setup
The code is stated to be portable, but you’re probably less likely to encounter
compilation errors if you’re running on a Unix platform. A Sun machine was used in this
case.
Make a sub-directory in your home directory and change-directory to it
mkdir ~/heath
cd heath
Use ftp to download heathusf_v1.1.0.tar.gz into the heath subdirectory
ftp marathon.csee.usf.edu
login: “anonymous” (without the “ ”)
password: (just hit enter)
cd pub/heathusf
bin (make sure you’re in binary transfer mode)
get heathusf_v1.1.0.tar.gz
bye
Uncompress and untar the software and compile the programs by using the following
commands:
cd ~/heath
gunzip -c heathusf_v1.1.0.tar.gz | tar -xvf cd code
build_heathusf
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MATLAB can import TIFF images. So we will use Heath’s code to convert the LJPEG
files to TIFF. Three executables will be required for this process, “case_decompress”,
“mkimage”, “jpeg”.
You should find the “case_decompress” executable all ready compiled in the
subdirectory “.../heath/code/compression”. “jpeg” should be in
.../heath/code/compression/JPEG/PVRG/jpegdir. If it’s not do the following:
cd ~/heath/code/compression/JPEG/PVRG/jpegdir
make
You will have to compile “mkimage”. A file called “libmammo.a” is required. You will
have to create this file in the heath/code/common subdirectory running an executable
called build_library.
cd ~/heath/code/common
build_library
Compile the mkimage using its makefile
cd ~/heath/code/image
make
Since you’ll need to call these executables from various sub-directories you’ll want to set
paths to the directories of these files. Edit your .login file to include the following paths
to these executables
setenv PATH .../heath/code/image:$PATH
setenv PATH .../heath/code/compression:$PATH
setenv PATH .../heath/code/compression/JPEG/PVRG/jpegdir:$PATH
NOTE: You should replace the “...” with your home directory
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Finally, copy “jpeg” into the same sub-directory as “case_decompress”.
cd ~/heath/code/compression
cp ~/heath/code/compression/JPEG/PVRG/jpegdir/jpeg

.

NOTE: “case_decompress” calls “jpeg” when it runs. The paths we included in the .login
file allow “jpeg” to be found and executed from any subdirectory when typed in at the
command prompt. However “case_decompress” will only be able to find “jpeg” if it’s in
the same directory with it.
Running the Programs
Change directory to a directory where you have a case of images. Run case_decompress
to decompress the files
case_decompress
A LJPEG.1 file will be decompressed from each of the four LPJEG files. Convert these
files to TIFF format using “mkimage” replacing <FILENAME> with the name of the .ics
file you’ll find with each the case of images (example: A-0003-1.ics, A-0565-1.ics)
mkimage –ics <FILENAME> –view LEFT_CC -tif
mkimage –ics <FILENAME> –view RIGHT_CC -tif
mkimage –ics <FILENAME> –view LEFT_MLO -tif
mkimage –ics <FILENAME> –view RIGHT_MLO -tif
You should now have 4 TIFF image files for viewing in MATLAB
Handling TIFF Images in MATLAB
TIFF images of can be viewed and manipulated in MATLAB.
Start Matlab.
Go to File -> Import Data.
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Locate the TIFF file you wish to view.
The Import Wizard window will appear, just click the “finish” button at the bottom.
You should see the TIFF image as matrix in the workspace window. (You might consider
shortening the rather long file name (e.g. A_0002_1.LEFT_CC.LJPEG.1.image.tif). For
this example the TIFF image matrix will be renamed “X”.) To view the TIFF image enter
the following commands into MATLAB’s command window.
colormap('gray')
imagesc(X)
Imagesc() simply displays the matrix as pixel map. colormap() imposes a grayscale
colormapping scheme on the image.
A “figure No.” window will appear with the TIFF image inside. The image however will
more than likely be skewed as the aspect ratio of the image is not automatically adjusted
when it is imported into MATLAB. To correct this, go to the drop down menu figure
window and do the following.
Go to “Edit”
Under edit select “Figure properties”
A “Property editor – Figure” window will appear. In that widow:
Go to “Edit Properties for:” drop down menu at the top and click once.
It will open down and you’ll see “Root”, “Figure”, “Axes” & “Image” options
Select “Image”
Then click the button that says “Fix axis to image”
You should now see the TIFF image properly displayed in the “Figure No.1” window.
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APPENDIX B
ELLIPSE TEST SETS
SET 1
Dimensions
pxw – pixel width (unit of length)
px – pixels (unit of area)
Angles test

Calculated quantities - ellipse_angle_at_0.tif
101.0792
Semi-major axis (pxw)
49.5092
Semi-minor axis (pxw)
87.7320
Angle
1.572162e+004
Area of Fitted Ellipse
16000.0000
Area of tumor (px)
0.9824
Ratio of difference in area
0.8718
Eccentricity
1.491547e+000
Shape conformity (pxw)
0.9942
R-squared
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Calculated quantities - ellipse_angle_at_15.tif
101.5012
Semi-major axis (pxw)
49.8448
Semi-minor axis (pxw)
103.9678
Angle
1.589427e+004
Area of Fitted Ellipse
16014.0000
Area of tumor (px)
0.9925
Ratio of difference in area
0.8711
Eccentricity
9.596332e-001
Shape conformity (pxw)
0.9985
R-squared
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Calculated quantities - ellipse_angle_at_30.tif
101.4027
Semi-major axis (pxw)
49.9270
Semi-minor axis (pxw)
119.2192
Angle
1.590502e+004
Area of Fitted Ellipse
16037.0000
Area of tumor (px)
0.9917
Ratio of difference in area
0.8704
Eccentricity
8.773067e-001
Shape conformity (pxw)
0.9987
R-squared

55

Calculated quantities - ellipse_angle_at_45.tif
101.2052
Semi-major axis (pxw)
50.0843
Semi-minor axis (pxw)
137.4026
Angle
1.592407e+004
Area of Fitted Ellipse
16043.0000
Area of tumor (px)
0.9926
Ratio of difference in area
0.8690
Eccentricity
1.539821e+000
Shape conformity (pxw)
0.9939
R-squared
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Calculated quantities - ellispe_angle_at_60.tif
101.4027
Semi-major axis (pxw)
49.9229
Semi-minor axis (pxw)
150.7808
Angle
1.590374e+004
Area of Fitted Ellipse
16037.0000
Area of tumor (px)
0.9917
Ratio of difference in area
0.8704
Eccentricity
8.779854e-001
Shape conformity (pxw)
0.9987
R-squared
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Calculated quantities - ellispe_angle_at_75.tif
101.5012
Semi-major axis (pxw)
49.6660
Semi-minor axis (pxw)
166.0322
Angle
1.583728e+004
Area of Fitted Ellipse
16013.0000
Area of tumor (px)
0.9890
Ratio of difference in area
0.8721
Eccentricity
1.017578e+000
Shape conformity (pxw)
0.9984
R-squared
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Calculated quantities - ellispe_angle_at_90.tif
101.0792
Semi-major axis (pxw)
49.5003
Semi-minor axis (pxw)
2.2680
Angle
1.571879e+004
Area of Fitted Ellipse
15998.0000
Area of tumor (px)
0.9824
Ratio of difference in area
0.8719
Eccentricity
1.490115e+000
Shape conformity (pxw)
0.9944
R-squared
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Calculated quantities - ellispe_angle_at_105.tif
101.5012
Semi-major axis (pxw)
49.8448
Semi-minor axis (pxw)
13.9678
Angle
1.589427e+004
Area of Fitted Ellipse
16014.0000
Area of tumor (px)
0.9925
Ratio of difference in area
0.8711
Eccentricity
9.596332e-001
Shape conformity (pxw)
0.9985
R-squared
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Calculated quantities - ellipse_angle_at_120.tif
101.4027
Semi-major axis (pxw)
49.9270
Semi-minor axis (pxw)
29.2192
Angle
1.590502e+004
Area of Fitted Ellipse
16037.0000
Area of tumor (px)
0.9917
Ratio of difference in area
0.8704
Eccentricity
8.773067e-001
Shape conformity (pxw)
0.9987
R-squared
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Calculated quantities - ellispe_angle_at_135.tif
101.2052
Semi-major axis (pxw)
50.0843
Semi-minor axis (pxw)
47.4026
Angle
1.592407e+004
Area of Fitted Ellipse
16043.0000
Area of tumor (px)
0.9926
Ratio of difference in area
0.8690
Eccentricity
1.539821e+000
Shape conformity (pxw)
0.9940
R-squared
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Calculated quantities - ellispe_angle_at_150.tif
101.4027
Semi-major axis (pxw)
49.9229
Semi-minor axis (pxw)
60.7808
Angle
1.590374e+004
Area of Fitted Ellipse
16037.0000
Area of tumor (px)
0.9917
Ratio of difference in area
0.8704
Eccentricity
8.779854e-001
Shape conformity (pxw)
0.9987
R-squared
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Calculated quantities - ellispe_angle_at_165.tif
101.5012
Semi-major axis (pxw)
49.6660
Semi-minor axis (pxw)
76.0322
Angle
1.583728e+004
Area of Fitted Ellipse
16013.0000
Area of tumor (px)
0.9890
Ratio of difference in area
0.8721
Eccentricity
1.017578e+000
Shape conformity (pxw)
0.9984
R-squared
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Calculated quantities - ellispe_angle_at_180.tif
101.0792
Semi-major axis (pxw)
49.5003
Semi-minor axis (pxw)
92.2680
Angle
1.571881e+004
Area of Fitted Ellipse
15998.0000
Area of tumor (px)
0.9824
Ratio of difference in area
0.8719
Eccentricity
1.490109e+000
Shape conformity (pxw)
0.9941
R-squared
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APPENDIX B
SET 2
Dimensions
pxw – pixel width (unit of length)
px – pixels (unit of area)
Eccentricity examples for horizontal ellipses

Calculated quantities - Ellispe_ecc_at_0.tif
101.0012
Semi-major axis (pxw)
0.4951
Semi-minor axis (pxw)
90.2836
Angle
1.570824e+002
Area of Fitted Ellipse
202.0000
Area of tumor (px)
0.7498
Ratio of difference in area
1.0000
Eccentricity
6.378707e-001
Shape conformity (pxw)
0.1733
R-squared
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Calculated quantities - Ellispe_ecc_at_20.tif
101.0111
Semi-major axis (pxw)
19.5040
Semi-minor axis (pxw)
90.8509
Angle
6.189329e+003
Area of Fitted Ellipse
6494.0000
Area of tumor (px)
0.9520
Ratio of difference in area
0.9812
Eccentricity
1.135740e+000
Shape conformity (pxw)
0.9959
R-squared
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Calculated quantities - ellispe_ecc_at_40.tif
101.0445
Semi-major axis (pxw)
39.5009
Semi-minor axis (pxw)
91.7014
Angle
1.253919e+004
Area of Fitted Ellipse
12830.0000
Area of tumor (px)
0.9771
Ratio of difference in area
0.9204
Eccentricity
1.391722e+000
Shape conformity (pxw)
0.9957
R-squared
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Calculated quantities - ellispe_ecc_at_60.tif
101.1002
Semi-major axis (pxw)
59.5000
Semi-minor axis (pxw)
87.4489
Angle
1.889813e+004
Area of Fitted Ellipse
19146.0000
Area of tumor (px)
0.9870
Ratio of difference in area
0.8085
Eccentricity
1.398127e+000
Shape conformity (pxw)
0.9938
R-squared
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Calculated quantities - ellipse_ecc_at_80.tif
101.1781
Semi-major axis (pxw)
79.4997
Semi-minor axis (pxw)
86.6003
Angle
2.526978e+004
Area of Fitted Ellipse
25478.0000
Area of tumor (px)
0.9918
Ratio of difference in area
0.6186
Eccentricity
1.161083e+000
Shape conformity (pxw)
0.9871
R-squared

70

Calculated quantities - ellispe_ecc_at_100.tif
101.5800
Semi-major axis (pxw)
99.4995
Semi-minor axis (pxw)
163.7060
Angle
3.175258e+004
Area of Fitted Ellipse
31814.0000
Area of tumor (px)
0.9981
Ratio of difference in area
0.2014
Eccentricity
9.518279e-001
Shape conformity (pxw)
-0.1608
R-squared
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APPENDIX B
SET 3
Dimensions
pxw – pixel width (unit of length)
px – pixels (unit of area)
Eccentricity examples for vertical ellipses

Calculated quantities – ellipse_ecc_at_100.tif
101.5800
Semi-major axis (pxw)
99.4995
Semi-minor axis (pxw)
163.7060
Angle
3.175258e+004
Area of Fitted Ellipse
31814.0000
Area of tumor (px)
0.9981
Ratio of difference in area
0.2014
Eccentricity
9.518279e-001
Shape conformity (pxw)
-0.1608
R-squared
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Calculated quantities - ellipse_ecc_at_80.tif
101.1781
Semi-major axis (pxw)
79.4997
Semi-minor axis (pxw)
86.6003
Angle
2.526978e+004
Area of Fitted Ellipse
25478.0000
Area of tumor (px)
0.9918
Ratio of difference in area
0.6186
Eccentricity
1.161083e+000
Shape conformity (pxw)
0.9871
R-squared
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Calculated quantities - ellipse_ecc_at_60.tif
101.1002
Semi-major axis (pxw)
59.5000
Semi-minor axis (pxw)
87.4489
Angle
1.889813e+004
Area of Fitted Ellipse
19146.0000
Area of tumor (px)
0.9870
Ratio of difference in area
0.8085
Eccentricity
1.398127e+000
Shape conformity (pxw)
0.9938
R-squared
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Calculated quantities - ellipse_ecc_at_40.tif
101.0445
Semi-major axis (pxw)
39.5009
Semi-minor axis (pxw)
91.7014
Angle
1.253919e+004
Area of Fitted Ellipse
12830.0000
Area of tumor (px)
0.9771
Ratio of difference in area
0.9204
Eccentricity
1.391722e+000
Shape conformity (pxw)
0.9957
R-squared
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Calculated quantities - ellipse_ecc_at_20.tif
101.0111
Semi-major axis (pxw)
19.5040
Semi-minor axis (pxw)
90.8509
Angle
6.189329e+003
Area of Fitted Ellipse
6494.0000
Area of tumor (px)
0.9520
Ratio of difference in area
0.9812
Eccentricity
1.135740e+000
Shape conformity (pxw)
0.9959
R-squared
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Calculated quantities - ellipse_ecc_at_0.tif
101.0012
Semi-major axis (pxw)
0.4951
Semi-minor axis (pxw)
90.2836
Angle
1.570824e+002
Area of Fitted Ellipse
202.0000
Area of tumor (px)
0.7498
Ratio of difference in area
1.0000
Eccentricity
6.378707e-001
Shape conformity (pxw)
0.1733
R-squared
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APPENDIX B
SET 4
Dimensions
pxw – pixel width (unit of length)
px – pixels (unit of area)
Size examples

Calculated quantities - FittedEllipse1.tif
1.5811
Semi-major axis (pxw)
0.4243
Semi-minor axis (pxw)
71.5651
Angle
2.107444e+000
Area of Fitted Ellipse
3.0000
Area of tumor (px)
0.6505
Ratio of difference in area
0.9633
Eccentricity
0.4417
Shape conformity (pxw)
0.0270
R-squared
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Calculated quantities - ellispe_siz_at_3.tif
4.3012
Semi-major axis (pxw)
2.4963
Semi-minor axis (pxw)
144.4623
Angle
3.373096e+001
Area of Fitted Ellipse
38.0000
Area of tumor (px)
0.8810
Ratio of difference in area
0.8144
Eccentricity
7.037949e-001
Shape conformity (pxw)
-0.0778
R-squared
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Calculated quantities - ellispe_siz_at_5.tif
6.5192
Semi-major axis (pxw)
4.4953
Semi-minor axis (pxw)
147.5288
Angle
9.206654e+001
Area of Fitted Ellipse
98.0000
Area of tumor (px)
0.9376
Ratio of difference in area
0.7242
Eccentricity
7.635382e-001
Shape conformity (pxw)
0.0104
R-squared
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Calculated quantities - FittedEllipse10.tif
6.1847
Semi-major axis (pxw)
4.4984
Semi-minor axis (pxw)
165.9638
Angle
8.740236e+001
Area of Fitted Ellipse
90.0000
Area of tumor (px)
0.9707
Ratio of difference in area
0.6863
Eccentricity
6.314390e-001
Shape conformity (pxw)
-0.1700
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APPENDIX C – THE CIRCULAR PERMUTATION MATRIX S
The circular permutation matrix S is a matrix that when multiplied with a matrix M
results in a circular permutation of the elements in M. The direction in which the
elements in M are shifted depends on whether M is left multiplied or right multiplied by
S or its transpose ST. For example,

MS = shifts elements in M one column to the right.
MS T = shifts elements in M one column to the left.
SM = shifts elements in M up one row.
S T M = shifts elements in M down one row.
Elements shifted out of the bounds of the matrix M are re-introduced on the
opposite side. In other words elements leaving out right most column of M reappear in
the 1st column of M. Elements shifted out of bottom row of M become the top row of
ST M .

The size of S must be commensurate with the size of M. Regardless of the size of
M, S is always a square matrix of size N with ones along the upper off diagonal and a one
in the 1st column on the bottom row of S. All other elements in S are zero. Concisely, the
elements of S are,

si,i+1 = 1 for i = 1,N-1
sN,1 = 1
For a square matrix M with dimensions 4×4, S is constructed as,
0
0
S =
0
1

1
0
0
0

0
1
0
0

0
0
1
0

, for M 5×5,
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0
0
S =0
0
1

1
0
0
0
0

0
1
0
0
0

0
0
1
0
0

0
0
0
1
0

1
0
0
0
0
0

0
1
0
0
0
0

0
0
1
0
0
0

0
0
0
1
0
0

, for M 6×6,
0
0
0
S =
0
0
1

0
0
0
0
1
0

...and so forth.
In general, M is an m-by-n matrix. When M has rectangular dimensions two different
circular shift matrices, Sm and Sn, of size m and n respectively are required. Sm and Sn are
applied as follows,
MS n = shifts elements in M right.
MS Tn = shifts elements in M left.

S m M = shifts elements in M up.
S Tm M = shifts elements in M down.

, where Sm is a square matrix of size m and Sn is a square matrix of size n.
The matrix S is useful for taking image derivatives.
ΔI left = I − I ⋅ S T

ΔI right = I − I ⋅ S
ΔI up = I − S ⋅ I
ΔI down = I − S T ⋅ I
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